Indication and Description BAQSIMI™ is indicated for the treatment of severe hypoglycemia in patients with diabetes ages 4 years and above. BAQSIMI contains glucagon, an antihypoglycemic agent used to treat severe hypoglycemia. Dosage in Adults and...





